REHMANN CAPITAL ADVISORY GROUP – Vertex Pharmaceuticals Incorporated Transaction History
REHMANN CAPITAL ADVISORY GROUP portfolio value:
$731,957
portfolio value
REHMANN CAPITAL ADVISORY GROUP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +9.53% | 220 shares | 81.58K | $289.54 | 2.52K |
| Q2 2022 | share | Decrease | -17.57% | -492 shares | -94.17K | $281.79 | 2.30K |
| Q1 2022 | share | Increase | +16.28% | 392 shares | 215.75K | $260.97 | 2.8K |
| Q4 2021 | share | Decrease | -6.41% | -165 shares | 62.62K | $222.45 | 2.40K |
| Q3 2021 | share | Decrease | -3.05% | -81 shares | -36.08K | $181.39 | 2.57K |
| Q2 2021 | share | Increase | +26.20% | 551 shares | 50.99K | $201.63 | 2.65K |
| Q1 2021 | share | Increase | +15.30% | 279 shares | 20.18K | $214.89 | 2.10K |
| Q4 2020 | share | Decrease | -10.06% | -204 shares | -120.77K | $236.34 | 1.82K |
| Q3 2020 | share | Increase | +5.68% | 109 shares | -5.24K | $272.12 | 2.02K |
| Q2 2020 | share | Increase | +26.17% | 398 shares | 195.18K | $290.31 | 1.91K |
| Q1 2020 | share | Decrease | -21.96% | -428 shares | 31.72K | $237.95 | 1.52K |
| Q3 2019 | share | Increase | +342.95% | 1.50K shares | 249.51K | $169.42 | 1.94K |
| Q2 2019 | share | Decrease | -0.23% | -1 shares | -434 | $183.38 | 440 |
| Q1 2019 | share | Increase | +7.82% | 32 shares | 13.34K | $183.95 | 441 |
| Q4 2018 | share | Increase | +22.46% | 75 shares | 3.4K | $165.71 | 409 |
| Q3 2018 | share | Decrease | -11.17% | -42 shares | 470 | $192.74 | 334 |
| Q2 2018 | share | Decrease | -73.10% | -1.02K shares | -164.09K | $169.96 | 376 |
| Q1 2018 | share | Increase | 0.00% | 1.39K shares | 228K | $162.98 | 1.39K |